IPO registrations (S-1, F-1) · Registrants

KIORA PHARMACEUTICALS INC

SEC CIK
1372514 · filings on EDGAR ↗
Former names
EYEGATE PHARMACEUTICALS INC (2006–2021)
Registration
Form S-1, first filed 2014-07-30, last 2023-06-01; 8 initial registrations, 21 amendments
Outcome
Final prospectus filed 2015-02-13; declared effective 2015-02-12; withdrawal requested 2016-10-31
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
169 SAXONY RD., SUITE 212, Encinitas, CA 92024
EIN
98-0443284
Ticker
KPRX, KPHMW (Nasdaq, OTC)
EDGAR entity type
operating
Insiders and CEO pay
KIORA PHARMACEUTICALS INC on the corporate pages

Offering terms

Final price
$6.00 per share (424B4 filed 2015-02-13, an initial public offering)
Shares sold
683,250
Gross proceeds
$4,099,500 before underwriting discounts and any over-allotment option
Listing
OTCQB under the symbol EYEG
Lead underwriters
Aegis Capital (341,625 shares)
Syndicate
Chardan (341,625)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 50

FiledFormWhat it isName as filedEDGAR
2014-07-30S-1S-1 (registration)EYEGATE PHARMACEUTICALS INC0001144204-14-045707 ↗
2014-08-08S-1/AS-1/A (amendment)EYEGATE PHARMACEUTICALS INC0001144204-14-048143 ↗
2014-08-29S-1/AS-1/A (amendment)EYEGATE PHARMACEUTICALS INC0001144204-14-053333 ↗
2014-09-12S-1/AS-1/A (amendment)EYEGATE PHARMACEUTICALS INC0001144204-14-055714 ↗
2014-09-29S-1/AS-1/A (amendment)EYEGATE PHARMACEUTICALS INC0001144204-14-058162 ↗
2014-11-20S-1/AS-1/A (amendment)EYEGATE PHARMACEUTICALS INC0001144204-14-070114 ↗
2014-12-02S-1/AS-1/A (amendment)EYEGATE PHARMACEUTICALS INC0001144204-14-071658 ↗
2014-12-24S-1/AS-1/A (amendment)EYEGATE PHARMACEUTICALS INC0001144204-14-075901 ↗
2015-01-26S-1/AS-1/A (amendment)EYEGATE PHARMACEUTICALS INC0001144204-15-003738 ↗
2015-02-04S-1/AS-1/A (amendment)EYEGATE PHARMACEUTICALS INC0001144204-15-005804 ↗
2015-02-12EFFECTEFFECT (declared effective)EYEGATE PHARMACEUTICALS INC9999999995-15-000404 ↗
2015-02-13424B4424B4 (final prospectus)EYEGATE PHARMACEUTICALS INC0001144204-15-009184 ↗
2015-06-05S-1S-1 (registration)EYEGATE PHARMACEUTICALS INC0001144204-15-035843 ↗
2015-07-15S-1/AS-1/A (amendment)EYEGATE PHARMACEUTICALS INC0001144204-15-042717 ↗
2015-07-28S-1/AS-1/A (amendment)EYEGATE PHARMACEUTICALS INC0001144204-15-044597 ↗
2015-07-30S-1/AS-1/A (amendment)EYEGATE PHARMACEUTICALS INC0001144204-15-044920 ↗
2015-07-30S-1/AS-1/A (amendment)EYEGATE PHARMACEUTICALS INC0001144204-15-045116 ↗
2015-07-30EFFECTEFFECT (declared effective)EYEGATE PHARMACEUTICALS INC9999999995-15-002115 ↗
2015-07-31424B4424B4 (final prospectus)EYEGATE PHARMACEUTICALS INC0001144204-15-045565 ↗
2016-05-06EFFECTEFFECT (declared effective)EYEGATE PHARMACEUTICALS INC9999999995-16-004571 ↗
2016-10-31RWRW (withdrawal request)EYEGATE PHARMACEUTICALS INC0001144204-16-130563 ↗
2017-04-21S-1S-1 (registration)EYEGATE PHARMACEUTICALS INC0001144204-17-021542 ↗
2017-05-05S-1/AS-1/A (amendment)EYEGATE PHARMACEUTICALS INC0001144204-17-024866 ↗
2017-06-05S-1/AS-1/A (amendment)EYEGATE PHARMACEUTICALS INC0001144204-17-031012 ↗
2017-06-08S-1MEFS-1MEF (added securities)EYEGATE PHARMACEUTICALS INC0001144204-17-031800 ↗
2017-06-08EFFECTEFFECT (declared effective)EYEGATE PHARMACEUTICALS INC9999999995-17-001483 ↗
2017-06-12424B4424B4 (final prospectus)EYEGATE PHARMACEUTICALS INC0001144204-17-032033 ↗
2018-03-23S-1S-1 (registration)EYEGATE PHARMACEUTICALS INC0001571049-18-000192 ↗
2018-04-09S-1/AS-1/A (amendment)EYEGATE PHARMACEUTICALS INC0001144204-18-019713 ↗
2018-04-12EFFECTEFFECT (declared effective)EYEGATE PHARMACEUTICALS INC9999999995-18-000816 ↗
2018-04-16424B4424B4 (final prospectus)EYEGATE PHARMACEUTICALS INC0001144204-18-020581 ↗
2019-05-13EFFECTEFFECT (declared effective)EYEGATE PHARMACEUTICALS INC9999999995-19-001106 ↗
2019-11-18EFFECTEFFECT (declared effective)EYEGATE PHARMACEUTICALS INC9999999995-19-002598 ↗
2021-04-30EFFECTEFFECT (declared effective)EYEGATE PHARMACEUTICALS INC9999999995-21-001694 ↗
2022-05-03S-1S-1 (registration)KIORA PHARMACEUTICALS INC0001104659-22-055297 ↗
2022-07-13S-1/AS-1/A (amendment)KIORA PHARMACEUTICALS INC0001104659-22-079591 ↗
2022-07-19S-1/AS-1/A (amendment)KIORA PHARMACEUTICALS INC0001104659-22-080880 ↗
2022-07-21S-1/AS-1/A (amendment)KIORA PHARMACEUTICALS INC0001104659-22-081271 ↗
2022-07-21EFFECTEFFECT (declared effective)KIORA PHARMACEUTICALS INC9999999995-22-002123 ↗
2022-07-25424B1424B1 (final prospectus)KIORA PHARMACEUTICALS INC0001104659-22-082104 ↗
2022-12-22S-1S-1 (registration)KIORA PHARMACEUTICALS INC0001104659-22-129237 ↗
2022-12-28EFFECTEFFECT (declared effective)KIORA PHARMACEUTICALS INC9999999995-22-003657 ↗
2023-02-03S-1S-1 (registration)KIORA PHARMACEUTICALS INC0001104659-23-010675 ↗
2023-02-13EFFECTEFFECT (declared effective)KIORA PHARMACEUTICALS INC9999999995-23-000410 ↗
2023-05-05S-1S-1 (registration)KIORA PHARMACEUTICALS INC0001628280-23-016198 ↗
2023-05-12S-1/AS-1/A (amendment)KIORA PHARMACEUTICALS INC0001628280-23-017953 ↗
2023-06-01S-1/AS-1/A (amendment)KIORA PHARMACEUTICALS INC0001372514-23-000085 ↗
2023-06-01EFFECTEFFECT (declared effective)KIORA PHARMACEUTICALS INC9999999995-23-001605 ↗
2023-06-02424B1424B1 (final prospectus)KIORA PHARMACEUTICALS INC0001372514-23-000090 ↗
2024-03-28EFFECTEFFECT (declared effective)KIORA PHARMACEUTICALS INC9999999995-24-000765 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2015-02-04S-1/Aregistration statement$6.00833,333$4,999,998OTCQB EYEG2primary document; price sentence, shares headline, proceeds computed, cover names 2document ↗
2015-02-13424B4final prospectus$6.00683,250$4,099,500OTCQB EYEG2primary document; price sentence, shares headline, proceeds table, underwriting table 2, cover names 2document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
BALLAND THOMASDirector82015–2017
CHANEY PAUL GDirector152015–2023
Chaoui MouniaDirector72015–2016
FCPR VENTECH BTenPercentOwner22015
FROM STEPHENDirector,Officer; Director,Officer,TenPercentOwner; OfficerExecutive Chairman; President and CEO512015–2022
GOLDBERG MORTONDirector182015–2021
HANCOCK THOMASDirector122015–2021
IPSA (INNOVEN PARTENAIRES S.A.)TenPercentOwner22015
MALFROY-CAMINE BERNARDDirector122015–2021
MANZO MICHAEL P.OfficerVice President of Engineering; VP of Engineering412015–2021
NATIXIS PRIVATE EQUITYTenPercentOwner22015
TYLE PRAVEENDirector192015–2026
Ventech Capital IITenPercentOwner52015–2017
Mann BrendaOfficerVP of Research & Development392016–2021
Wirostko BarbaraOfficerChief Medical Officer172016–2019
Brenneman Ryan RandallOfficerChief Financial Officer32016
Romano SarahOfficerChief Financial Officer; Interim CFO432017–2022
Garanzini MichaelOfficerChief Commercial Officer52017–2018
ARMISTICE CAPITAL, LLCDirector,TenPercentOwner; TenPercentOwner182018–2021
Armistice Capital Master Fund Ltd.Director,TenPercentOwner; TenPercentOwner182018–2021
Boyd StevenDirector,TenPercentOwner; TenPercentOwner182018–2021
Greenleaf PeterDirector32018–2019
Maher Illya KeithDirector12020
Obermayr FranzOfficerActing CEO22021
Shapiro AronDirector92021–2026
Gayron Kenneth LDirector52021–2023
Strem Brian M.Director,OfficerPresident and CEO142021–2026
Daniels Eric JosephOfficerChief Development Officer132021–2026
Hollander DavidDirector72021–2026
Parsons ErinDirector82022–2026
Drexler Susan L.OfficerInterim CFO12022
Tosca MelissaOfficerCFO; EVP Finance; EVP of Finance112022–2026
Stengone Carmine N.Director62023–2026
Walters-Hoffert LisaDirector52024–2026
Lane Keith J.Other22026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2026-04-21KIORA PHARMACEUTICALS INCPharmaceuticals$5,000,000$5,000,00031
2024-02-14KIORA PHARMACEUTICALS INCPharmaceuticals$15,000,000$15,000,000131
2023-02-17KIORA PHARMACEUTICALS INCPharmaceuticals$10,000,000$011
2023-02-17KIORA PHARMACEUTICALS INCPharmaceuticals$200,000$200,00011
2021-11-04EYEGATE PHARMACEUTICALS INCPharmaceuticalsIndefinite$67,25861
2021-08-23EYEGATE PHARMACEUTICALS INCPharmaceuticals$10,750,013$10,750,013141
2021-01-21EYEGATE PHARMACEUTICALS INCPharmaceuticals$8,000,003$8,000,00311
2021-01-04EYEGATE PHARMACEUTICALS INCPharmaceuticalsIndefinite$3,203,083151
2020-01-15EYEGATE PHARMACEUTICALS INCPharmaceuticalsIndefinite$051
2019-10-08EYEGATE PHARMACEUTICALS INCPharmaceuticals$1,875,000$1,875,00011
2016-07-07EYEGATE PHARMACEUTICALS INCPharmaceuticals$3,768,750$3,768,75021
2016-03-21EYEGATE PHARMACEUTICALS INCPharmaceuticals$2,618,797$2,618,797321
2014-07-24EYEGATE PHARMACEUTICALS INCBiotechnology$2,000,000$994,843181

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Plan sponsorKIORA PHARMACEUTICALS, INC.CAForm 5500 (employee benefit plans)EIN (EXACT)
Form D issuerKIORA PHARMACEUTICALS INCCAForm D private offeringsCIK (EXACT)
SEC filerKIORA PHARMACEUTICALS INCSEC filers (EDGAR)CIK (EXACT)
Trademark ownerKIORA PHARMACEUTICALS, INC.CATrademarks (USPTO)name and state
Form 5500 plan sponsorKIORA PHARMACEUTICALS, INC.EIN (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, CA first:

More with this interest.

In other datasets, the same topic (Health) in CA:

Interests: Pharmaceutical Preparations · Health